... bind to the site are considered to be top hits for validation and further optimization as drug candidates.
Five other compounds known to experimentally bind to avian influenza N1 were also screened, ...
... in my lab and works to develop models that will facilitate the evaluation of the safety and effectiveness of drug candidates designed to combat retinal disease in humans, has done superb work in this ...
... 's Scripps Research laboratory laid the groundwork for this therapeutic strategy and discovered the drug candidate. "Moreover, this is the first pharmacologic evidence that the biomedical researcher ...
... and Stroke (NINDS) and by the Families of SMA funding program.
Correcting RNA splicing
The drug candidate targets the splicing of a gene called SMN2, which is essentially a back-up copy to the ...
... overcome this hurdle and develop an inhibitor with greater specificity, and therefore greater potential as a drug candidate, Marmorstein and his colleagues set out to create a lipid kinase inhibitor ...
... to treat adenovirus infections in large part because there has been no animal model in which to test drug candidates, a key prerequisite before testing in humans.
SLU researchers and their ...
... of which were established in mice over 20 years ago, emerged in our search for platinum anticancer drug candidates with cellular uptake properties analogous or superior to those of oxaliplatin," said ...
... team was able to screen more than 1,200 drug candidates and find clemizole in just two ... strongly. That led them to realize which kind of drug - a small-molecule compound - could block that interaction ...
... PLoS Pathogens, the team is searching for new drugs that may someday allow infected people to be cured ... Implications:
Collins' lab is now screening drug candidates to find promising Nef inhibitors. ...
... and Université Louis Pasteur in Strasbourg, France, which are providing the chemicals being screened for drug candidates. Biotech company NanoMedica has shown interest in commercializing the process. ...
... age-related macular degeneration (AMD) is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab...
... is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab. AMD is a leading cause of vision loss in ...
... candidates for treating H5N1 avian flu.
McCammon's team is now focusing on designing even ... enzymes makes an inhibitor less attractive as a drug candidate because the interactions could cause undesired ...
... Dr. Buccafusco says.
Dr. Buccafusco also cited several novel drug candidates developed at the MCG Alzheimer's Research Center, including two molecules prevent cell death in the ...
... Illinois chemist Rong Cao began by producing crystallographic structures of the target enzymes and drug candidates, allowing the researchers to identify those features that would enhance the drugs' ...
